VICENTE DAMIÁN
ESCUDERO VILAPLANA
Profesor asociado de Ciencias de la Salud
Carmen Guadalupe
Rodríguez González
Publicaciones en las que colabora con Carmen Guadalupe Rodríguez González (12)
2022
-
Implementation and evaluation of a home pharmaceutical care model through Telepharmacy
Farmacia Hospitalaria, Vol. 46, pp. 36-46
2021
-
COVID-19 in hospitalised patients in Spain: a cohort study in Madrid
International Journal of Antimicrobial Agents, Vol. 57, Núm. 2
-
Error detection and cost savings with an image-based workflow management system connected to a computerized prescription order entry program for antineoplastic compounding
Journal of Patient Safety, Vol. 17, Núm. 8, pp. E1589-E1594
2020
-
Evaluation of the use, effectiveness and safety of tyrosine kinase inhibitors in chronic myelogenous leukaemia in a general university hospital
European Journal of Hospital Pharmacy, Vol. 27, Núm. 5, pp. 299-301
-
Risks and medication errors analysis to evaluate the impact of a chemotherapy compounding workflow management system on cancer patients’ safety
Health Informatics Journal, Vol. 26, Núm. 3, pp. 1995-2010
2019
-
Development and Evaluation of a Clinical Decision Support System to Improve Medication Safety
Applied Clinical Informatics, Vol. 10, Núm. 3, pp. 513-520
-
Robotic dispensing improves patient safety, inventory management, and staff satisfaction in an outpatient hospital pharmacy
Journal of Evaluation in Clinical Practice, Vol. 25, Núm. 1, pp. 28-35
2018
-
Twelve weeks of ombitasvir/paritaprevir/r and dasabuvir without ribavirin is effective and safe in the treatment of patients with HCV genotype 1b infection and compensated cirrhosis: results from a real-world cohort study
Expert Opinion on Drug Safety, Vol. 17, Núm. 3, pp. 235-241
2017
-
Improving pharmacotherapy outcomes in patients with hepatitis C virus infection treated with direct-acting antivirals: The GRUviC project
International Journal of Clinical Practice, Vol. 71, Núm. 8
2016
-
Effectiveness and Safety of Ombitasvir-Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin for HCV Genotype 1 Infection for 12 Weeks Under Routine Clinical Practice
Annals of Pharmacotherapy, Vol. 50, Núm. 11, pp. 901-908
2013
-
Equipotent doses of pegylated epoetin β (CERA) for the treatment of outcome patients with anemia secondary to chronic kidney disease in clinical practice
Atencion Farmaceutica, Vol. 15, Núm. 1, pp. 55-58
-
Permanencia del tratamiento antirretroviral de última generación en la práctica clínica diaria
Farmacia Hospitalaria, Vol. 37, Núm. 2, pp. 151-155